New Barcode Rule: Every Pill Gets a Digital ID

European pharmaceutical associations, including EAHP and EFPIA, are urging the expanded use of barcodes to cover individual doses of medication. This proposed change mandates that all new pharmaceutical products will feature barcodes on each single unit dose starting in 2031, with existing medicines to be updated gradually. This initiative aims to bolster patient safety and hospital efficiency by reducing medication errors, which studies indicate can be cut by 30% to 60% through bedside scanning.

The implementation of unique identifiers on single doses, such as vials and syringes, is a significant step beyond the current requirement for barcodes on multi-packs and certain prescription medicines within the EU since 2019. Research suggests that printing barcodes on individual doses could decrease error rates by 41%. Overcoming challenges related to packaging dimensions and manufacturer investment is key to realizing use cases like direct electronic patient record entry.

Nathalie Moll, EFPIA's director general, stated that all new medicines will carry a barcode on every dose within the next five years. This advancement is expected to improve the use of healthcare resources and deliver substantial progress in patient care. The initiative represents a continued digitization of medication dispensing processes.